Showing results (151-160 of 161) with videos related to
Sort By:
Pageof 17
Annals of Neurology|September 4, 2003
A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's diseaseC Warren Olanow, Christopher G Goetz, Jeffrey H Kordower, et al.Pain|August 27, 2021
OnabotulinumtoxinA affects cortical recovery period but not occurrence or propagation of cortical spreading depression in rats with compromised blood-brain barrierAgustin Melo-Carrillo, Andrew M Strassman, Aaron J Schain, et al.Aesthetic Surgery Journal|July 14, 2026
Safety and Efficacy of TrenibotulinumtoxinE for Moderate-to-Severe Glabellar Lines: A Phase 2b, Double-Blind, Placebo-Controlled, Dose-Escalation StudyEdward Lain, Leslie Baumann, Suzanne Bruce, et al.Movement Disorders : Official Journal of the Movement Disorder Society|August 26, 2010
Meta-analysis of neutralizing antibody conversion with onabotulinumtoxinA (BOTOX®) across multiple indicationsMarkus Naumann, Alastair Carruthers, Jean Carruthers, et al.The Journal of Biological Chemistry|April 11, 2008
Novel chimeras of botulinum neurotoxins A and E unveil contributions from the binding, translocation, and protease domains to their functional characteristicsJiafu Wang, Jianghui Meng, Gary W Lawrence, et al.Aesthetic Surgery Journal|October 15, 2025
OnabotulinumtoxinA Treatment for Masseter Muscle Prominence: 6-Month Safety and Efficacy Results, Including Patient-Reported Outcomes, From a Phase 3, Randomized, Placebo-Controlled, Multiregional TrialJiaming Sun, Lei Wang, Yan Wu, et al.American Heart Journal|October 23, 2021
Design and Rationale of a Phase 2 Study of NeurOtoxin (Botulinum Toxin Type A) for the PreVention of Post-Operative Atrial Fibrillation - The NOVA StudyJonathan P Piccini, Anders Ahlsson, Paul Dorian, et al.Annals of Neurology|October 29, 2002
Epsilon-sarcoglycan mutations found in combination with other dystonia gene mutationsChristine Klein, Liu Liu, Dana Doheny, et al.Movement Disorders : Official Journal of the Movement Disorder Society|January 5, 2008
Phenotypic spectrum and sex effects in eleven myoclonus-dystonia families with epsilon-sarcoglycan mutationsDeborah Raymond, Rachel Saunders-Pullman, Patricia de Carvalho Aguiar, et al.Journal of Clinical Lipidology|October 15, 2022
Guidance for the diagnosis and treatment of hypolipidemia disordersCindy Bredefeld, M Mahmood Hussain, Maurizio Averna, et al.Pageof 17